DMK Pharma Sues Drug Co. It Claims Helped Drive It To Ch. 11

By Clara Geoghegan · June 4, 2024, 6:20 PM EDT

Drug developer DMK Pharmaceuticals has asked a Delaware bankruptcy judge to award it $328.7 million from pharmaceutical company US WorldMeds LLC, saying USWM didn't properly market an opioid-overdose intervention product, resulting...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

DMK Pharmaceuticals has applied for Chapter 11 protection in Delaware, citing recent clinical trial failures and product recalls, as well as the government's allegation that a subsidiary engaged in criminal activities, as reasons for seeking bankruptcy relief.

Case Number

24-10153

Judge

Mary F. Walrath

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$13.9M

View Full Scorecard

Documents

Complaint